Nighttime PTS trading information is displayed, with Euglena’s share price holding around ¥351. The company reported higher revenue and profits, returning to profitability, supported by growth in its healthcare business and improvements in its cost structure.
The nighttime PTS trading price is displayed at ¥351.2 (20:24), with an opening price of ¥353, a high of ¥353, a low of ¥351.2, trading volume of 700 shares and a trading value of ¥246 thousand. The nighttime trading data is listed as nighttime trading information for J-Market, operated by JapanNext Securities. These figures are 0.06% higher than the closing price in the Tokyo market. The nighttime PTS trading price is also said to affect the indicator showing the difference from the TSE closing price.
According to the financial results, interim revenue for the fiscal year ending December 2026 was ¥26.5 billion, up 8.0% year on year, operating profit was ¥1.9 billion, up 14.3%, ordinary profit was ¥1.7 billion, up 45.8%, and interim net income attributable to owners of the parent was ¥73 million, representing a return to profitability. The company said growth in its healthcare business and improvements in its cost structure contributed to the results.
As part of its outlook, the company indicated that holding an international algae conference in Malaysia on 16 September formed part of its business strategy, and that developments in the algae sector have coincided with periods of a recovery in the share price. In Japan, the company is working to create demand through the launch of HVO supply, while construction of a commercial plant is progressing as planned through its Malaysian joint venture. These initiatives are said to have the potential to expand earnings opportunities.